Sallyport Commercial Finance funded a $4 million facility for Belluscura, a medical device company focused on developing innovative oxygen enrichment technology. The funding, comprising accounts receivable and cash flow loans, is designed to empower Belluscura to expand its operations into the U.S. market.
“Sallyport is proud to fuel innovation and growth for companies like Belluscura,” Nick Hart, president of Sallyport Commercial Finance, said. “This funding underscores our commitment to empowering businesses to deliver life-enhancing solutions, such as their groundbreaking oxygen devices, to a global market.”
